Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 41, Issue 11, 2008, Pages 971-975

  Duncan, C N ^a   Buonanno, M R ^a   Barry, E V ^a   Myers, K ^a   Peritz, D ^a   Lehmann, L ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CALCINEURIN INHIBITOR; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOSTATIN; PRAVASTATIN; RAPAMYCIN;

ADD ON THERAPY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BRONCHIOLITIS OBLITERANS; CHILDHOOD MORTALITY; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE COURSE; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL; HUMAN; INCIDENCE; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG INFECTION; LUNG INJURY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; THORAX RADIOGRAPHY;

BRONCHIOLITIS OBLITERANS; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; VITAL CAPACITY;

EID: 45449112641     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.19     Document Type: Article

References (23)

1. Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: Analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003; 9: 657-666.
2. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368-376.
3. Frankovich J, Donaldson SS, Lee Y, Wong RM, Amylon M, Verneris MR. High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: Atopy predicts idiopathic diffuse lung injury syndromes. Biol Blood Marrow Transplant 2001; 7: 49-57.
4. Paz HL. Crilley P, Patchefsky A. Schiffman RL. Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992; 101: 775-778.
5. Yoshihara S. Tateishi U. Ando T, Kunitoh H, Suyama H, Onishi Y et al Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant 2005; 35: 1195-1200.
6. Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988; 72 621-627.
7. Sakaida E, Nakaseko C, Harima A, Yokota A, Cho R, Saito Y et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 2003; 102: 4236-4242.
8. Griese M, Rampf U, Hofmann D, Fuhrer M, Reinhardt D, Bender-Gotze C. Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000; 30: 393-401.
9. Wieringa J, van Kralingen KW, Sont JK, Bresters D. Pulmonary function impairment in children following hematopoietic stem cell transplantation. Pediatr Blood Cancer 2005; 45: 318-323.
10. Kurland G, Michelson P. Bronchiolitis obliterans in children. Pediatr Pulmonol 2005; 39: 193-208.
11. Mauad T, Dolhnikoff M. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol 2002; 33: 466-474.
12. Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Nichols WG et al. Airflow obstruction after myeloablative allogeneic hematopoietic stein cell transplantation. Am J Respir Crit Care Med 2003; 168: 208-214.
13. Ratjen F, Rjabko O, Kremens B. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplant 2005: 36: 135-138.
14. Santo Tomas LH. Loberiza Jr FR, Klein JP, Layde PM, Lipchik RJ. Rizzo JD et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005; 128: 153-161.
15. Schultz KR, Green GJ. Wensley D, Sargent MA, Magee JF, Spinelli JJ et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994: 84: 3212-3220.
16. Rovelli A, Pezzini C, Silvestri D. Tana F. Galli MA. Uderzo C. Cardiac and respiratory function after bone marrow transplantation in children with leukaemia. Bone Marrow Transplant 1995; 16: 571-576.
17. Quigley PM. Yeager AM, Loughlin GM. The effects of bone marrow transplantation on pulmonary function in children. Pediatr Pulmonol 1994; 18: 361-367.
18. Kaplan EB, Wodell RA, Wilmott RW. Leifer B, Lesser ML. August CS. Late effects of bone marrow transplantation on pulmonary function in children. Bone Marrow Transplant 1994: 14: 613-621.
19. Kaplan EB, Wodell RA. Wilmott RW, Leifer B, Lesser ML, August CS. Chronic graft-versus-host disease and pulmonary function. Pediatr Pulmonol 1992; 14: 141-148.
20. Nenadov Beck M, Meresse V, Hartmann O, Gaultier C. Long-term Pulmonary sequelae after autologous bone marrow transplantation in children without total body irradiation. Bone Marrow Transplant 1995; 16 771-775.
21. Frisk P, Arvidson J, Bratteby LE, Hedenstrom H, Lonnerholm G. Pulmonary function after autologous bone marrow transplantation in children: A long-term prospective study. Bone Marrow Transplant 2004; 33 645-650.
22. Arvidson J, Bratteby LE. Carlson K. Hagberg H, Kreuger A, Simonsson B et al. Pulmonary function after autologous bone marrow transplantation in children. Bone Marrow Transplant 1994; 14 117-123.
23. Leneveu H, Bremont F, Rubie H, Peyroulet MC, Broue A, Suc A et al. Respiratory function in children undergoing bone marrow transplantation. Pediatr Pulmonol 1999; 28: 31-38.